ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Hormone Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-25C13516
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Hormone Market Research Report 2023
BUY CHAPTERS

Global Recombinant Hormone Market Research Report 2024

Code: QYRE-Auto-25C13516
Report
August 2024
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eli Lilly and Company
Ferring Pharmaceuticals
Merck
Pfizer Inc
Novo Nordisk
Novartis
Ipsen S A
LG Chem
Teva Pharmaceutical
Scripps Laboratories

Recombinant Hormone Market

Recombinant hormones are hormones that are manufactured in a laboratory using recombinant technology for therapeutic purposes. The endocrine system in the human body consists of glands (pituitary, thyroid, parathyroid, adrenal, pancreas, etc.) that produce hormones that regulate metabolism, growth and development, reproduction, sexual function, tissue function and other functions. If hormone levels are too high or too low, there is a problem with the endocrine system.
The global Recombinant Hormone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Recombinant Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Hormone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Recombinant Hormone include Eli Lilly and Company, Ferring Pharmaceuticals, Merck, Pfizer, Novo Nordisk, Novartis AG, Ipsen, LG Chem and Teva Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hormone.

Report Scope

The Recombinant Hormone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Hormone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Hormone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Recombinant Hormone Market Report

Report Metric Details
Report Name Recombinant Hormone Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly and Company, Ferring Pharmaceuticals, Merck, Pfizer, Novo Nordisk, Novartis AG, Ipsen, LG Chem, Teva Pharmaceutical, Scripps Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Recombinant Hormone Market report?

Ans: The main players in the Recombinant Hormone Market are Eli Lilly and Company, Ferring Pharmaceuticals, Merck, Pfizer, Novo Nordisk, Novartis AG, Ipsen, LG Chem, Teva Pharmaceutical, Scripps Laboratories

What are the Application segmentation covered in the Recombinant Hormone Market report?

Ans: The Applications covered in the Recombinant Hormone Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Recombinant Hormone Market report?

Ans: The Types covered in the Recombinant Hormone Market report are Growth Hormone, Insulin, Follicle-stimulating Hormone, Others

Recommended Reports

Recombinant Hormones

Hormone Drugs

Hormone Disorders

1 Recombinant Hormone Market Overview
1.1 Product Overview and Scope of Recombinant Hormone
1.2 Recombinant Hormone Segment by Type
1.2.1 Global Recombinant Hormone Market Value Comparison by Type (2024-2030)
1.2.2 Growth Hormone
1.2.3 Insulin
1.2.4 Follicle-stimulating Hormone
1.2.5 Others
1.3 Recombinant Hormone Segment by Application
1.3.1 Global Recombinant Hormone Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Recombinant Hormone Market Size Estimates and Forecasts
1.4.1 Global Recombinant Hormone Revenue 2019-2030
1.4.2 Global Recombinant Hormone Sales 2019-2030
1.4.3 Global Recombinant Hormone Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Hormone Market Competition by Manufacturers
2.1 Global Recombinant Hormone Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Hormone Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Hormone Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Hormone Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Hormone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Hormone, Product Type & Application
2.7 Recombinant Hormone Market Competitive Situation and Trends
2.7.1 Recombinant Hormone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Hormone Players Market Share by Revenue
2.7.3 Global Recombinant Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Hormone Retrospective Market Scenario by Region
3.1 Global Recombinant Hormone Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Hormone Global Recombinant Hormone Sales by Region: 2019-2030
3.2.1 Global Recombinant Hormone Sales by Region: 2019-2024
3.2.2 Global Recombinant Hormone Sales by Region: 2025-2030
3.3 Global Recombinant Hormone Global Recombinant Hormone Revenue by Region: 2019-2030
3.3.1 Global Recombinant Hormone Revenue by Region: 2019-2024
3.3.2 Global Recombinant Hormone Revenue by Region: 2025-2030
3.4 North America Recombinant Hormone Market Facts & Figures by Country
3.4.1 North America Recombinant Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Hormone Sales by Country (2019-2030)
3.4.3 North America Recombinant Hormone Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Hormone Market Facts & Figures by Country
3.5.1 Europe Recombinant Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Hormone Sales by Country (2019-2030)
3.5.3 Europe Recombinant Hormone Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Hormone Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Hormone Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Hormone Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Recombinant Hormone Market Facts & Figures by Country
3.7.1 Latin America Recombinant Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Hormone Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Hormone Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Hormone Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Hormone Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Hormone Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Hormone Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Hormone Sales by Type (2019-2030)
4.1.1 Global Recombinant Hormone Sales by Type (2019-2024)
4.1.2 Global Recombinant Hormone Sales by Type (2025-2030)
4.1.3 Global Recombinant Hormone Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Hormone Revenue by Type (2019-2030)
4.2.1 Global Recombinant Hormone Revenue by Type (2019-2024)
4.2.2 Global Recombinant Hormone Revenue by Type (2025-2030)
4.2.3 Global Recombinant Hormone Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Hormone Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Hormone Sales by Application (2019-2030)
5.1.1 Global Recombinant Hormone Sales by Application (2019-2024)
5.1.2 Global Recombinant Hormone Sales by Application (2025-2030)
5.1.3 Global Recombinant Hormone Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Hormone Revenue by Application (2019-2030)
5.2.1 Global Recombinant Hormone Revenue by Application (2019-2024)
5.2.2 Global Recombinant Hormone Revenue by Application (2025-2030)
5.2.3 Global Recombinant Hormone Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Hormone Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly and Company Recombinant Hormone Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Ferring Pharmaceuticals
6.2.1 Ferring Pharmaceuticals Corporation Information
6.2.2 Ferring Pharmaceuticals Description and Business Overview
6.2.3 Ferring Pharmaceuticals Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ferring Pharmaceuticals Recombinant Hormone Product Portfolio
6.2.5 Ferring Pharmaceuticals Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Recombinant Hormone Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Recombinant Hormone Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Novo Nordisk
6.5.1 Novo Nordisk Corporation Information
6.5.2 Novo Nordisk Description and Business Overview
6.5.3 Novo Nordisk Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novo Nordisk Recombinant Hormone Product Portfolio
6.5.5 Novo Nordisk Recent Developments/Updates
6.6 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis AG Recombinant Hormone Product Portfolio
6.6.5 Novartis AG Recent Developments/Updates
6.7 Ipsen
6.6.1 Ipsen Corporation Information
6.6.2 Ipsen Description and Business Overview
6.6.3 Ipsen Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ipsen Recombinant Hormone Product Portfolio
6.7.5 Ipsen Recent Developments/Updates
6.8 LG Chem
6.8.1 LG Chem Corporation Information
6.8.2 LG Chem Description and Business Overview
6.8.3 LG Chem Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LG Chem Recombinant Hormone Product Portfolio
6.8.5 LG Chem Recent Developments/Updates
6.9 Teva Pharmaceutical
6.9.1 Teva Pharmaceutical Corporation Information
6.9.2 Teva Pharmaceutical Description and Business Overview
6.9.3 Teva Pharmaceutical Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teva Pharmaceutical Recombinant Hormone Product Portfolio
6.9.5 Teva Pharmaceutical Recent Developments/Updates
6.10 Scripps Laboratories
6.10.1 Scripps Laboratories Corporation Information
6.10.2 Scripps Laboratories Description and Business Overview
6.10.3 Scripps Laboratories Recombinant Hormone Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Scripps Laboratories Recombinant Hormone Product Portfolio
6.10.5 Scripps Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Hormone Industry Chain Analysis
7.2 Recombinant Hormone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Hormone Production Mode & Process
7.4 Recombinant Hormone Sales and Marketing
7.4.1 Recombinant Hormone Sales Channels
7.4.2 Recombinant Hormone Distributors
7.5 Recombinant Hormone Customers
8 Recombinant Hormone Market Dynamics
8.1 Recombinant Hormone Industry Trends
8.2 Recombinant Hormone Market Drivers
8.3 Recombinant Hormone Market Challenges
8.4 Recombinant Hormone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Eli Lilly and Company
Ferring Pharmaceuticals
Merck
Pfizer Inc
Novo Nordisk
Novartis
Ipsen S A
LG Chem
Teva Pharmaceutical
Scripps Laboratories
List of Tables
    Table 1. Global Recombinant Hormone Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Recombinant Hormone Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Recombinant Hormone Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Recombinant Hormone Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Recombinant Hormone Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Recombinant Hormone Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Recombinant Hormone Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Recombinant Hormone Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Recombinant Hormone, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Recombinant Hormone, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Recombinant Hormone, Product Type & Application
    Table 12. Global Key Manufacturers of Recombinant Hormone, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Recombinant Hormone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Hormone as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Recombinant Hormone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Recombinant Hormone Sales by Region (2019-2024) & (K Units)
    Table 18. Global Recombinant Hormone Sales Market Share by Region (2019-2024)
    Table 19. Global Recombinant Hormone Sales by Region (2025-2030) & (K Units)
    Table 20. Global Recombinant Hormone Sales Market Share by Region (2025-2030)
    Table 21. Global Recombinant Hormone Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Recombinant Hormone Revenue Market Share by Region (2019-2024)
    Table 23. Global Recombinant Hormone Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Recombinant Hormone Revenue Market Share by Region (2025-2030)
    Table 25. North America Recombinant Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Recombinant Hormone Sales by Country (2019-2024) & (K Units)
    Table 27. North America Recombinant Hormone Sales by Country (2025-2030) & (K Units)
    Table 28. North America Recombinant Hormone Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Recombinant Hormone Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Recombinant Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Recombinant Hormone Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Recombinant Hormone Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Recombinant Hormone Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Recombinant Hormone Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Recombinant Hormone Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Recombinant Hormone Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Recombinant Hormone Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Recombinant Hormone Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Recombinant Hormone Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Recombinant Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Recombinant Hormone Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Recombinant Hormone Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Recombinant Hormone Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Recombinant Hormone Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Recombinant Hormone Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Recombinant Hormone Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Recombinant Hormone Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Recombinant Hormone Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Recombinant Hormone Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Recombinant Hormone Sales (K Units) by Type (2019-2024)
    Table 51. Global Recombinant Hormone Sales (K Units) by Type (2025-2030)
    Table 52. Global Recombinant Hormone Sales Market Share by Type (2019-2024)
    Table 53. Global Recombinant Hormone Sales Market Share by Type (2025-2030)
    Table 54. Global Recombinant Hormone Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Recombinant Hormone Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Recombinant Hormone Revenue Market Share by Type (2019-2024)
    Table 57. Global Recombinant Hormone Revenue Market Share by Type (2025-2030)
    Table 58. Global Recombinant Hormone Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Recombinant Hormone Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Recombinant Hormone Sales (K Units) by Application (2019-2024)
    Table 61. Global Recombinant Hormone Sales (K Units) by Application (2025-2030)
    Table 62. Global Recombinant Hormone Sales Market Share by Application (2019-2024)
    Table 63. Global Recombinant Hormone Sales Market Share by Application (2025-2030)
    Table 64. Global Recombinant Hormone Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Recombinant Hormone Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Recombinant Hormone Revenue Market Share by Application (2019-2024)
    Table 67. Global Recombinant Hormone Revenue Market Share by Application (2025-2030)
    Table 68. Global Recombinant Hormone Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Recombinant Hormone Price (US$/Unit) by Application (2025-2030)
    Table 70. Eli Lilly and Company Corporation Information
    Table 71. Eli Lilly and Company Description and Business Overview
    Table 72. Eli Lilly and Company Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Eli Lilly and Company Recombinant Hormone Product
    Table 74. Eli Lilly and Company Recent Developments/Updates
    Table 75. Ferring Pharmaceuticals Corporation Information
    Table 76. Ferring Pharmaceuticals Description and Business Overview
    Table 77. Ferring Pharmaceuticals Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Ferring Pharmaceuticals Recombinant Hormone Product
    Table 79. Ferring Pharmaceuticals Recent Developments/Updates
    Table 80. Merck Corporation Information
    Table 81. Merck Description and Business Overview
    Table 82. Merck Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. Merck Recombinant Hormone Product
    Table 84. Merck Recent Developments/Updates
    Table 85. Pfizer Corporation Information
    Table 86. Pfizer Description and Business Overview
    Table 87. Pfizer Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Pfizer Recombinant Hormone Product
    Table 89. Pfizer Recent Developments/Updates
    Table 90. Novo Nordisk Corporation Information
    Table 91. Novo Nordisk Description and Business Overview
    Table 92. Novo Nordisk Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Novo Nordisk Recombinant Hormone Product
    Table 94. Novo Nordisk Recent Developments/Updates
    Table 95. Novartis AG Corporation Information
    Table 96. Novartis AG Description and Business Overview
    Table 97. Novartis AG Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Novartis AG Recombinant Hormone Product
    Table 99. Novartis AG Recent Developments/Updates
    Table 100. Ipsen Corporation Information
    Table 101. Ipsen Description and Business Overview
    Table 102. Ipsen Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Ipsen Recombinant Hormone Product
    Table 104. Ipsen Recent Developments/Updates
    Table 105. LG Chem Corporation Information
    Table 106. LG Chem Description and Business Overview
    Table 107. LG Chem Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. LG Chem Recombinant Hormone Product
    Table 109. LG Chem Recent Developments/Updates
    Table 110. Teva Pharmaceutical Corporation Information
    Table 111. Teva Pharmaceutical Description and Business Overview
    Table 112. Teva Pharmaceutical Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Teva Pharmaceutical Recombinant Hormone Product
    Table 114. Teva Pharmaceutical Recent Developments/Updates
    Table 115. Scripps Laboratories Corporation Information
    Table 116. Scripps Laboratories Description and Business Overview
    Table 117. Scripps Laboratories Recombinant Hormone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Scripps Laboratories Recombinant Hormone Product
    Table 119. Scripps Laboratories Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Recombinant Hormone Distributors List
    Table 123. Recombinant Hormone Customers List
    Table 124. Recombinant Hormone Market Trends
    Table 125. Recombinant Hormone Market Drivers
    Table 126. Recombinant Hormone Market Challenges
    Table 127. Recombinant Hormone Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Recombinant Hormone
    Figure 2. Global Recombinant Hormone Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Recombinant Hormone Market Share by Type in 2023 & 2030
    Figure 4. Growth Hormone Product Picture
    Figure 5. Insulin Product Picture
    Figure 6. Follicle-stimulating Hormone Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Recombinant Hormone Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Recombinant Hormone Market Share by Application in 2023 & 2030
    Figure 10. Hospital
    Figure 11. Clinic
    Figure 12. Others
    Figure 13. Global Recombinant Hormone Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Recombinant Hormone Market Size (2019-2030) & (US$ Million)
    Figure 15. Global Recombinant Hormone Sales (2019-2030) & (K Units)
    Figure 16. Global Recombinant Hormone Average Price (US$/Unit) & (2019-2030)
    Figure 17. Recombinant Hormone Report Years Considered
    Figure 18. Recombinant Hormone Sales Share by Manufacturers in 2023
    Figure 19. Global Recombinant Hormone Revenue Share by Manufacturers in 2023
    Figure 20. The Global 5 and 10 Largest Recombinant Hormone Players: Market Share by Revenue in 2023
    Figure 21. Recombinant Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 22. Global Recombinant Hormone Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 23. North America Recombinant Hormone Sales Market Share by Country (2019-2030)
    Figure 24. North America Recombinant Hormone Revenue Market Share by Country (2019-2030)
    Figure 25. United States Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Canada Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Europe Recombinant Hormone Sales Market Share by Country (2019-2030)
    Figure 28. Europe Recombinant Hormone Revenue Market Share by Country (2019-2030)
    Figure 29. Germany Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. France Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. U.K. Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Italy Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Russia Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Recombinant Hormone Sales Market Share by Region (2019-2030)
    Figure 35. Asia Pacific Recombinant Hormone Revenue Market Share by Region (2019-2030)
    Figure 36. China Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Japan Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. South Korea Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. India Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Australia Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Indonesia Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Thailand Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Malaysia Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Recombinant Hormone Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Recombinant Hormone Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Recombinant Hormone Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Recombinant Hormone Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. UAE Recombinant Hormone Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Recombinant Hormone by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Recombinant Hormone by Type (2019-2030)
    Figure 57. Global Recombinant Hormone Price (US$/Unit) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Recombinant Hormone by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Recombinant Hormone by Application (2019-2030)
    Figure 60. Global Recombinant Hormone Price (US$/Unit) by Application (2019-2030)
    Figure 61. Recombinant Hormone Value Chain
    Figure 62. Recombinant Hormone Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Recombinant Growth Hormone Market Research Report 2024
Global Recombinant Human Growth Hormone Market Research Report 2025
Recombinant Human Parathyroid Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Human Follicle stimulating Hormone Market
Recombinant Follicle Stimulating Hormone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Synthetic Hormones Market Research Report 2025
Global Recombinant Human Somatropin for Injection Market Research Report 2024
Global Recombinant Protein Peptide Drug Market Research Report 2024
Bioidentical Hormones Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant Human Insulin Market Insights Forecast to 2030
Global Compounded Bioidentical Hormone Therapy Market Research Report 2025
Global Injectable Reproductive Hormone Market Insights Forecast to 2030
Global Recombinant Antibody Market Research Report 2025
Global Gene Recombinant Protein Market Research Report 2024
Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Recombinant FSH Injections Market Research Report 2024
Global Human Recombinant Insulin Market Research Report 2024
Global Reproductive Hormone Market Insights Forecast to 2030
Global Endocrine Testing Market Research Report 2024
Global Recombinant Human Transforming Growth Factor β Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions